NCT04447599

Brief Summary

The purpose of the study is to use a simple photography of conjunctival vessels to search for an association between conjunctival vessels abnormalities and the load of small vessel disease as quantified by MRI in patients with TIA s and minor strokes. The artificial intelligence (AI) tools will permit to classify abnormalities of conjunctival vessels that predict the load of small vessel disease in TIAs and strokes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
850

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2020

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 25, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

October 20, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2022

Completed
Last Updated

August 31, 2021

Status Verified

August 1, 2021

Enrollment Period

2 years

First QC Date

May 8, 2020

Last Update Submit

August 30, 2021

Conditions

Keywords

small vessel diseaseSTRIVE recommendationsartificial intelligence in " deep learning "bulbar conjunctiva photographyMRIscreeningfundus

Outcome Measures

Primary Outcomes (1)

  • Numbers of conjunctival vascular abnormalities

    Association between numbers of conjunctival vascular abnormalities and the load of small cerebral disease highlighted by neural network in " deep learning ". This outcome is collected after the end of the inclusion of all patients.

    day 1

Secondary Outcomes (3)

  • Classification of different types of vascular abnormalities in different grades of small vessel disease

    Day 1

  • Absence of difference between the 2 eyes

    Day 1

  • same stade of vascular abnormalities

    Day 1

Study Arms (1)

Photographs

EXPERIMENTAL

Photographs

Other: photography of conjunctival vessels

Interventions

patient will have photo of their bulbar conjunctival of each eye and photography of fundus without dilatation

Photographs

Eligibility Criteria

Age55 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients treated for a minor stroke or transient ischemic attack justifying an MRI.

You may not qualify if:

  • Severe eye dryness with conjunctiva hyperhemia,
  • Taking eye treatments for glaucoma
  • Inflammatory or infectious eye damage resulting in conjunctiva hyperhemia: conjunctivitis, herpetic keratitis, ulcer, abscess, uveitis, peripheral ulcerative keratitis, interstitial keratitis, scleritis, episcleritis, pingueculitis, scarring eye pemphigoide, acute seizure by closing of the angle,
  • History of eye surgery. Among eye surgeries, those that can modify the conjunctiva are strabismus surgeries, glaucoma, conjunctiva resection surgery (pterygial or tumor) or wound surgery or finally recent cataract surgery (2 years).
  • Persons under the legal protection of adults (safeguarding justice, guardianship, curatorship, institutionalized, or under mandate of future protection)
  • Administrative problems: inability to give about informed information, no coverage by a social security plan, refusal to sign a consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NASR Nathalie

Toulouse, France

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Nathalie NASR, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nathalie NASR, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 8, 2020

First Posted

June 25, 2020

Study Start

October 20, 2020

Primary Completion

October 20, 2022

Study Completion

October 20, 2022

Last Updated

August 31, 2021

Record last verified: 2021-08

Locations